Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) stock is trading higher on Tuesday as the company is entering an exclusive global ...

Federal healthcare spending is projected to rise from less than $2 trillion today to more than $3 trillion within a decade, ...

As an autoimmune disease, alopecia areata can include unpredictable periods of hair loss and regrowth. It can be frustrating ...

Corcept raises 2026 revenue guidance after strong Korlym Q1 performance. New launches and pipeline progress may diversify future growth.

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) held its Annual General Meeting (“AGM”) today. A total of 92 per cent of the share capital was represented at the virtual assembly. All ...

Olema Pharmaceuticals awaits Phase 3 breast cancer data in fall 2026, with $505M in cash to fund catalysts. Learn why OLMA ...

Combining pre-formed vesicles with nucleic acid cargo at the point of care can remove long-standing barriers to personalized ...

Pharma stocks are gaining momentum as obesity drugs, oncology therapies and biotech innovation boost investor optimism.

With the help of DNA testing company Natera and its personalized molecular residual disease (MRD) blood test Signatera, Roche ...

Hundreds of executives and investors are pushing for Rick Pazdur to be the next FDA commissioner. Elsewhere, Takeda detailed its latest restructuring and Alumis is discarding a once-highly touted ...

Roche said its $4.3 billion takeover of Spark Therapeutics remained on track despite failing to get enough votes to clinch ...

Dana Cimilluca is former Wall Street bureau chief at The Wall Street Journal, where he managed a group of reporters and editors covering banks, hedge funds, private-equity firms, M&A and IPOs. He ...